Company Profile
Updated: 17-SEP-09Pressure BioSciences Inc.
Public Company, Headquarters Location
14 Norfolk Ave., South Easton, MA 02375-1907, United States
(508)230-1828, (508)230-1829 fax, http://www.pressurebiosciences.com
Primary SIC: In Vitro & In Vivo Diagnostic Agents, Primary NAICS: In-Vitro Diagnostic Substance Manufacturing
Description: Manufacturing: Medical test kits for detection and treatment of infectious diseases.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
PRESSURE BIOSCIENCES REPORTS ACQUISITION BY DIRECTOR FRITZSCHE (Massachusetts)
US Fed News Service, Including US State News; 12/5/2009; 298 words; WASHINGTON, Dec. 5 -- Pressure Biosciences Inc. (PBIO), South Easton, Mass., has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial...
Reportlinker Adds HPLC Systems & Accessories - A World Market Review.
PR Newswire; 12/2/2009; 1851 words; ...Review" by BizAcumen, Inc. Our reports are designed...OUTLOOK 4 Performing Under Pressure: The Versatile HPLC 4 Market...18 Agilent Technologies, Inc. (USA) 18 Dionex Corp. (USA) 18 ESA Biosciences, Inc. (USA) 18 Hitachi High...
Strategies for Building Early-Stage Pharmaceutical Pipelines Through External Sources.
M2 Presswire; 11/20/2009; 999 words; ...announced the addition of Decision Resources, Inc.'s new report "Strategies for Building...to their offering. Under tremendous pressure to refuel dwindling development pipelines...Alnylam Pharmaceuticals - Amgen - Ardea Biosciences - Astellas Pharma - Astex Technology...
Research and Markets: Strategies for Building Early-Stage Pharmaceutical Pipelines Through External Sources.
Business Wire; 11/20/2009; 917 words; ...announced the addition of Decision Resources, Inc.'s new report "Strategies for Building...to their offering. Under tremendous pressure to refuel dwindling development pipelines...Alnylam Pharmaceuticals * Amgen * Ardea Biosciences * Astellas Pharma * Astex Technology...
Pressure BioSciences, Inc. Receives Over $1.1 million From the Initial Tranche of Private Placement.
Investrend; 11/19/2009; 686 words; ...www.financialwire.net/2009/11/19/pressure-biosciences-inc-receives-over-1-1-million-from-the...November 19, 2009 (FinancialWire) -- Pressure BioSciences, Inc. (NASDAQ: PBIO) has closed on the sale of...
Recent News Articles
- Pressure BioSciences, Inc. Provides Corporate Update.
PR Newswire - March 20, 2009 - Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008.
PR Newswire - March 04, 2009 - Pressure BioSciences, Inc. to Present at the EdgeWater Research Partners' Spring 2009 Micro/Small-Cap Investor Conference.
PR Newswire - February 26, 2009 - Pressure BioSciences Inc-Financial Company Report.
M2 Presswire - February 18, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning